omega-n-methylarginine has been researched along with Systemic Inflammatory Response Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamiyama, Y; Kitade, H; Kwon, AH; Okumura, T; Satoi, S; Tu, W; Zhang, Z | 1 |
Parrillo, JE; Phillip Dellinger, R | 1 |
2 other study(ies) available for omega-n-methylarginine and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Hepatocellular dysfunction induced by nitric oxide production in hepatocytes isolated from rats with sepsis.
Topics: Adenosine Triphosphate; Animals; Arginine; Cecum; Disease Models, Animal; Enzyme Inhibitors; Hepatocytes; Humans; Interleukin-1; Intestinal Perforation; Ketone Bodies; Ligation; Liver Diseases; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar; Recombinant Proteins; Systemic Inflammatory Response Syndrome | 2003 |
Mediator modulation therapy of severe sepsis and septic shock: does it work?
Topics: Bacteremia; Critical Care; Critical Illness; Female; Follow-Up Studies; Humans; Male; omega-N-Methylarginine; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Shock, Septic; Survival Analysis; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2004 |